Friday , April 26 2024
Home / Mike Norman Economics / The Week — Pharmaceutical company CEO says he has a ‘moral requirement’ to sell drugs at the highest price

The Week — Pharmaceutical company CEO says he has a ‘moral requirement’ to sell drugs at the highest price

Summary:
Because "shareholder value." [Nirmal Mulye, chief executive of Nostrum Laboratories,] told FT he agreed with Martin "Pharma Bro" Shkreli raising the price of AIDS and cancer drug Daraprim in 2015 from .50 to 0 per tablet, saying he was "within his rights because he had to reward his shareholders." We live in a "capitalist economy and if you can't make money you can't stay in business," Mulye said. "We have to make money when we can. Appropriately, nirman means "no mind."The Week Pharmaceutical company CEO says he has a 'moral requirement' to sell drugs at the highest price Catherine Garcia

Topics:
Mike Norman considers the following as important: ,

This could be interesting, too:

Joel Eissenberg writes Capitalism prevails

Daniel Becker writes Our relationship of work, technology and life

Mike Norman writes My new podcast episode is out

Matias Vernengo writes On the Worldly Philosophy at Radio UNAL


Because "shareholder value."
[Nirmal Mulye, chief executive of Nostrum Laboratories,] told FT he agreed with Martin "Pharma Bro" Shkreli raising the price of AIDS and cancer drug Daraprim in 2015 from $13.50 to $750 per tablet, saying he was "within his rights because he had to reward his shareholders."
We live in a "capitalist economy and if you can't make money you can't stay in business," Mulye said. "We have to make money when we can.
Appropriately, nirman means "no mind."

The Week

Catherine Garcia

Mike Norman
Mike Norman is an economist and veteran trader whose career has spanned over 30 years on Wall Street. He is a former member and trader on the CME, NYMEX, COMEX and NYFE and he managed money for one of the largest hedge funds and ran a prop trading desk for Credit Suisse.

Leave a Reply

Your email address will not be published. Required fields are marked *